开发一种风险分层工具,以预测患有妊娠期糖尿病的患者面临胰岛素治疗风险:一项队列研究
Xi Yang1,2, Hannah L Nathan3, Ebruba E Oyekan3
1Department of Women and Children's Heath, King's College London, London SE1 7EH, UK.
Journal of personalized medicine
|June 25, 2025
概括
一个新的风险工具准确地识别了不太可能需要胰岛素的妊娠糖尿病患者. 这种简单,经过验证的方法有助于对患有GDM的孕妇进行分拣护理,改善了资源分配.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 临床风险预测预测
背景情况:
- 妊娠期糖尿病 (GDM) 诊断需要有效的风险分层来指导治疗决策.
- 确定不太可能需要胰岛素治疗的患者对于有效的临床管理至关重要.
研究的目的:
- 为GDM开发和验证一个简单,用户友好的风险分层工具.
- 为了确定那些不太可能需要胰岛素治疗的GDM患者.
主要方法:
- 使用2019年GDM患者数据的多变量逻辑回归来开发胰岛素需求的预测模型.
- 通过对关键变量进行二分化,创建了一个分层工具:禁食血糖,预订BMI和诊断时的妊娠周.
- 使用内部 (2021) 和外部患者队列验证了该工具的性能.
主要成果:
- 更高的禁食血糖和预订的BMI与增加的胰岛素需求有关.
- 诊断时更晚的妊娠周与胰岛素治疗风险较低相关.
- 低风险标准 (禁食葡萄糖<5.6 mmol/L,BMI<30 kg/m2,诊断≥24周) 显示高负预测值 (90-94%) 和良好的灵敏度 (77-84%) 在整个队列.
结论:
- 一个务实的,三项标准的工具有效地分层了不需要胰岛素的GDM患者.
- 经过验证的工具在管理GDM方面显示出实际临床应用的前景.
- 这种分层有助于识别低风险的GDM患者,优化治疗途径.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Insulin: Dosing Regimen and Adverse Effects
270
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
270
Diabetes: Symptoms, Diagnosis, and Complications
709
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
709
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310


